ondansetron has been researched along with Jejunal Diseases in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grondahi, ML | 1 |
| Jensen, GM | 1 |
| Skadhauge, E | 1 |
| Hansen, MB | 1 |
1 other study available for ondansetron and Jejunal Diseases
| Article | Year |
|---|---|
Effect of 5-HT2 and 5-HT3 receptor antagonists on cholera toxin-induced fluid hypersecretion in the pig jejunum.
Topics: Analysis of Variance; Animals; Cholera Toxin; Dose-Response Relationship, Drug; Granisetron; Indoles | 1996 |